CJC-1295 + Ipamorelin 5 mg + 5 mgPachet de 10 flacoane6 în stocEconomisiți 22%
Recomandatpeptideintermediate6 în stoc

CJC-1295 + Ipamorelin 5 mg + 5 mg

Stack clasic analog GHRH + mimetic al ghrelinei

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Doză
5mg + 5mg / flacon
Formă
Pulbere liofilizată
Pachet
Pachet de 10 flacoane

Numai pentru uz de cercetare. Acest compus se vinde strict pentru cercetare in vitro și scopuri de laborator și nu este destinat consumului uman sau uzului terapeutic. Prin cumpărare confirmi că ești un cercetător calificat și ești de acord cu declinarea noastră completă.

926 lei RON
Economisiți 22%
Pachet de 10 flacoane
Era 1.186 lei RON
Vândut în pachet de 10 flacoane

Mai sunt doar 6 pachete

🧪Verificat în laborator
✓Testat de terți
⚡Livrare rapidă la nivel mondial
🔒Plată securizată cu cardul
Prezentare generală

Flacon de cercetare combinat care asociază analogul GHRH CJC-1295 cu mimeticul selectiv al ghrelinei Ipamorelin. Cel mai studiat stack de secretagogi GH cu dublu mecanism în cercetarea peptidelor.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Mecanism

CJC-1295 susține semnalizarea bazală a receptorului GHRH, în timp ce Ipamorelin conduce pulsuri selective ale receptorului ghrelinei. Cercetarea sugerează tipare sinergice, naturaliste de eliberare a GH la subiecții de studiu.

Raport de laborator

Verificat HPLC față de o specificație de puritate ≥99%. Testat independent de laboratoare terțe acreditate.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ pentru cercetători

CJC-1295 + Ipamorelin — întrebări frecvente

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Lecturi suplimentare

Ghiduri legate de CJC-1295 + Ipamorelin

Compuși relaționați

Cercetătorii explorează și

TesamorelinPachet de 10 flacoaneEconomisiți 18%

Tesamorelin

Pulbere liofilizată

10 mg · 3 strengths

Analog GHRH stabilizat

În 1 stack
1.758 lei RON
Economisiți 18%
Pachet de 10 flacoane
Era 2.142 lei RON
Vezi detalii →
Melanotan IIRecomandatPachet de 10 flacoaneEconomisiți 22%

Melanotan II

Pulbere liofilizată

10 mg

Peptid de cercetare analog α-MSH

556 lei RON
Economisiți 22%
Pachet de 10 flacoane
Era 712 lei RON
Vezi detalii →